Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics

Qian Li1, Fei Dong1, Biao Jiang1

  • 1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Frontiers in Oncology
|June 10, 2021
PubMed
Abstract

Insights

Brain diffuse midline gliomas (DMG-M) with H3 K27M mutations show similar MRI characteristics to wild-type tumors. Cystic formation on T2-weighted images may help diagnose DMG-M.

Area of Science:

  • Neuro-oncology
  • Radiology
  • Medical imaging analysis

Background:

  • Diffuse midline gliomas (DMGs) are aggressive brain tumors.
  • The H3 K27M mutation is a key molecular marker in DMGs.
  • Radiomics offers potential for non-invasive tumor characterization.

Purpose of the Study:

  • To investigate the MRI radiomic features of H3 K27M-mutant DMGs (DMG-M) versus wild-type DMGs (DMG-W).
  • To identify imaging biomarkers for differentiating these tumor types.

Main Methods:

  • Retrospective analysis of 30 DMG patients (16 DMG-M, 14 DMG-W).
  • Extraction and analysis of 272 radiomic features from MRI scans.
  • Application of feature selection techniques (PCA, univariate, variance thresholding, RFE, elastic net).
  • Evaluation of visually accessible T2-weighted imaging features.

Main Results:

  • DMG-M patients were significantly younger (median 25.5 vs 48 years).
  • Radiomic feature analysis showed minimal differentiation between DMG-M and DMG-W.
  • Cystic formation on T2-weighted images was the only significant differentiating feature (OR=7.800, p=0.024).

Conclusions:

  • DMGs with and without H3 K27M mutation exhibit largely overlapping MRI characteristics.
  • T2-weighted imaging sequences are valuable for DMG assessment.
  • Cystic formation is a potential MRI biomarker for diagnosing brain DMG-M.